FEATURING INVITATION-ONLY:
CHIEF COMPLIANCE OFFICER ROUNDTABLE
(Jointly Sponsored by PCF and PhRMA; Special November 6 Morning Session, Invitation-only)
FEATURING
Sally Molloy, JD
Acting Chief, Strategy, Policy & Training Unit, Fraud Section, Former Assistant U.S. Attorney, US Attorney’s Office, Northern District of Georgia, US Department of Justice, Washington, DC
KEYNOTE SPEAKERS
Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD
Brian Allen Benczkowski, JD
Assistant Attorney General, Criminal Division, US Department of Justice, Principal Deputy Assistant Attorney General for Legislative Affairs Former Republican Staff Director, Committee on the Judiciary, US Senate Former Staff, Senator Pete Domenici and Representative Jim Sensenbrenner, Washington, DC
Alexandra Christina, Countess of Frederiksborg
Member, Board of Directors – Chairperson Ethics and Compliance Board Committee, Ferring Pharmaceuticals, Co-author, The Sincerity Edge, Former Poling Chair of Business and Government, Kelley School of Business, Indiana University, Copenhagen, Denmark
Susan Dentzer
Visiting Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC
Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant U.S. Attorney, US Attorney’s Office, Western District of Michigan, Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC
Daniel Ronald Levinson, JD
Former Inspector General, US Department of Health and Human Services, Former Inspector General, US General Services Administration, Former Chairman, US Merit Systems Protection Board, Former General Counsel, US Consumer Product Safety Commission, Washington, DC
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
James Sheehan, JD
Chief, Charities Bureau at Attorney General of New York, Former Chief Integrity Officer, Executive Deputy Commissioner, City of New York Human Resources Administration, Former NY Medicaid Inspector General, Former Associate United States Attorney, US Attorney’s Office for the Eastern District of Pennsylvania, New York, NY
AND A FRIDAY, NOVEMBER 8 INDUSTRY-ONLY
BEST PRACTICES ROUNDTABLE
(Industry-only session for pharma and medical device compliance
professionals and in-house counsel only)
FEATURING
Jacob T. Elberg, JD
Associate Professor of Law, Seton Hall Law School, Former Chief, Health Care & Government
Fraud Unit and Assistant US Attorney, US Attorney’s Office, District of New Jersey, US
Department of Justice, Newark, NJ
FEATURED FACULTY
Meredith S. Auten, JD
Partner, Morgan Lewis, Co-chair, White Collar Committee Qui Tam Subcommittee, ABA Criminal Justice Section, Philadelphia, PA
Yogesh Bahl, CPA, MBA
Managing Director, AlixPartners, New York, NY
Ann E. Beasley, JD
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA
Thomas Beimers, JD
Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, Former Special Assistant United States Attorney, US Attorney’s Office, Eastern District of Michigan, Minneapolis, MN and Washington, DC
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC
Ela Bochenek, JD
Vice President and Chief Compliance Officer, Nabriva Therapeutics PLC, Former Assistant Dean Graduate & Professional Education, Seton Hall University School of Law, King of Prussia, PA
Kathleen M. Boozang, JD, LLM
Dean and Professor of Law, Seton Hall University School of Law, Newark, NJ
Bernadette M. Broccolo, JD
Partner, McDermott Will & Emery LLP, Chicago, IL
Christie Camelio
Vice President, Deputy Global Chief Compliance Officer, Celgene, Former Executive Director, Head of Risk Management Center of Excellence, Novartis Pharmaceuticals, Florham Park, NJ
Jennifer Chillas, JD
Senior Corporate Counsel, Bristol-Myers Squibb, New York, NY
John Claud, JD
Assistant Director, Consumer Protection Branch, US Department of Justice, Washington, DC
Brian Conner
Chief Compliance Officer, Strongbridge Biopharma plc, Former Assistant Compliance Officer of the Americas, Shire, Feasterville Trevose, PA
Thomas Costa, JD
Member, US Board of Directors, Sanofi, Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC
Jared D. Crafton
Principal, Assurance Services, Forensic & Integrity Services, EY, Boston, MA
Tiffany Cummings-Damiani, MBA
Vice President, Corporate and Healthcare Compliance, Global Compliance, Insmed, Former Senior Director, Global Compliance, Teva, Philadelphia, PA
Kris Curry, MBA
Principal, Assurance Services, EY, Former Vice President, Global Chief Compliance Officer, Pharma Sector, Johnson & Johnson, Philadelphia, PA
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
BJ D’Avella, MBA
Senior Manager, Deloitte Advisory, Deloitte & Touche LLP, New York, NY
Charlene E. Davis, JD
Associate Vice President & Head of Healthcare Compliance North America, Sun Pharmaceutical Industries, Princeton, NJ
CJ DeKreek, MBA
Senior Director, Ankura, Atlanta, GA
Julie DeLong, CFA
Senior Managing Director, Ankura Consulting Group, LLC, Atlanta, GA
Gary Del Vecchio
Health Care Compliance Officer Cardiovascular & Metabolism and Puerto Rico, Janssen; Former Executive Director, US Pharmaceutical Compliance and Ethics, BMS, Pennington, NJ
Mark A. DeWyngaert, PhD.
Managing Director, Deloitte Advisory, Deloitte & Touche LLP, Stamford, CT
Sarah diFrancesca, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
Christian A. Dingler
Associate Director, Navigant, Life Sciences, Richmond, VA
Stefanie A. Doebler, JD
Of Counsel, Covington & Burling LLP, Washington, DC
Adam Dubow, JD
Global Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ
Gildas Durand
Principal, Forensic & Integrity Services, EY, Miami, FL
Eileen Erdos
Principal, Forensic & Integrity Services, Chicago, IL
Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Purdue Pharma LP, Former Member, PCF Executive Committee, Stamford, CN
Alison Fethke, JD
Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL
Kellie Fidler, MBA, PMP
Director, Global Compliance Risk Mitigation & Monitoring Strategy, Bristol-Myers Squibb, Princeton, NJ
Elaina Filauro
Senior Manager, Deloitte Advisory, Deloitte & Touche LLP, New York, NY
Christine Fiore, MBA
Executive Director, Ethics and Commercial Compliance, Boehringer Ingelheim, Former Group Director Ethics and Compliance, Smith & Nephew, Ridgefield, CT
Jeffrey (Jeff) Fleming, JD
Assistant General Counsel, Pharma R&D, GlaxoSmithKline, Philadelphia, PA
Sarah A. Franklin, JD
Partner, and Vice-chair, Life Sciences Litigation and Investigations, Covington & Burling LLP, Former Attorney, Bureau of Consumer Protection, FTC, Washington, DC
Nereyda Garcia, JD
Global Head, Ethics and Compliance, Alnylam Pharmaceuticals, Cambridge, MA
Deeona Gaskin, MPH, JD
Associate, Sidley Austin LLP, Former Associate Chief Council, FDA, Washington, DC
Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY
Virginia “Ginny” A. Gibson, JD
Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
Noel Demetria Giglio, JD
Legal Counsel, Legal Compliance, Philips North America, LLC, Andover, MA
Thomas M. Glavin, JD
Chief Compliance Officer for the Americas, Olympus Corporation of the Americas; Former Vice President, US/Americas Compliance Officer, Shire, Center Valley, PA
Jonathan Glazier, MBA, JD
Head of Legal Compliance, Philips North America, Former Sr Director of Corporate Compliance and Privacy Officer, Fresenius Medical Care North America, Andover, MA
Kimberly J. Gold, JD, CIPP/US
Partner, Life Sciences Health Industry and Data Privacy Groups, Reed Smith, New York, NY
Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
Christine Gordon, JD
Deputy Chief Compliance Officer, Olympus Corporation of the Americas; Director, Board of Directors, ESSA Bancorp, Inc; Former Assistant District Attorney, Office of the District Attorney, City of Philadelphia, Bethlehem, PA
Kimi Gorman, CCEP, CFE
Director, Ethics & Compliance, Novo Nordisk Inc., Former Compliance Manager, B. Braun Medical, Princeton, NJ
Adam Greene, JD, MPH
Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP, Former Senior Health Information Technology and Privacy Specialist, Office for Civil Rights, HHS, Washington, DC
Amy Greenstein, JD/MSFS
Associate Principal, IQVIA, Boston, MA
Nancy Grygiel, JD
Vice President, Worldwide Compliance & Business Ethics, Amgen, Former Senior Director, Global Compliance, Mylan, Newbury Park, CA
Michael G. Hercz, JD
Senior Vice President & General Counsel, Sentynl Therapeutics, Inc., Solana Beach, CA
Rachael A. Honig, JD
First Assistant U.S. Attorney, U.S. Attorney’s Office, District of New Jersey, US Department of Justice; Former Corporate Counsel, Litigation, Celgene; Newark, NJ
Casey J. Horton, CFE
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL
William Hrubes, MS
Vice President and Chief Compliance Officer, ACell, Inc. Former Healthcare Compliance Officer, DePuy Orthopaedics, Columbia, MD
Pearl Hsieh, JD
Senior Counsel, US Commercial, Group Counsel, Smith & Nephew, Columbia, MD
Darren R. Jones, CIA
Senior Principal, Commercial Compliance, Global Consulting Practice Leader, IQVIA, New York, NY
Keith Korenchuk, MPH, JD
VP and Chief Compliance Officer Danaher Diagnostics and Beckman Coulter Diagnostics, DANAHER Corporation; Former Partner, Arnold & Porter Kaye Scholer; Chevy Chase, MD
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Puja Leekha, JD
Vice President, Chief Compliance Officer, and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC; Former Division Legal Counsel & Compliance Officer, Stryker Corporation; Deerfield, IL
Richard Liner, JD, MPH
Senior Counsel, Compliance & Investigations, Bayer Healthcare, Whippany, NJ
Mark Linver, MS
Managing Director, Deloitte & Touche LLP, Stamford, CT
Carrie Sarhangi Love, JD
Litigation Partner, Armstrong Teasdale LLP; Former Assistant District Attorney, Philadelphia; Philadelphia, PA
Ali Lyons
Senior Director, Ethics & Compliance, Aegerion Pharmaceuticals, a Novelion Therapeutics Company, Former Operations Lead, Ethics and Compliance, Eli Lilly and Company, Cambridge, MA
Jill Fallows Macaluso, JD, RN
Corporate Vice President, Chief Ethics & Compliance Officer, Novo Nordisk Inc., Princeton, NJ
Susan Markel
Managing Director, AlixPartners, Former Chief Accountant, Division of Enforcement, US Securities and Exchange Commission, Washington DC
Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Ridgefield, C
Heather McCollum, JD, MHA, CCEP-I
Director Compliance, Shionogi Inc., Florham Park, NJ
William A. McConagha, JD
Partner, Sidley Austin, LLP, Former Health Policy Advisor, Health, Education, Labor and Pensions Committee, US Senate, Former Assistant Commissioner, US Food and Drug Administration, Washington, DC
Jenny McVey, PhD
Compliance Risk & Mitigation, Novo Nordisk, Inc., Former Compliance Officer, Hands International, Princeton, NJ
Gregory S. Moss, JD
Senior Vice President, Deputy General Counsel, Kadmon Corporation, LLC, New York, NY
Kamleh J. Nicola, LLB
Partner, Baker & McKenzie LLP, Toronto, Canada
Katherine Norris, MPA
Director, Corporate Compliance & Risk Management, Berkeley Research Group LLC, Washington, DC
Dan O’Connor
Senior Vice President, PharmaCertify, a Division of NXLevel Solutions, New York, NY
Michael O’Connor
Vice President of Compliance Technology, Porzio Life Sciences, LLC, Former Global Head Compliance and Ethics Operations, Alexion, Former Executive Director, Global Head, IS Business Consulting, Boehringer Ingelheim, New York, NY
Amy Pawloski, CPA, PMP, CCEP
Compliance Officer-Operations, Endo Pharmaceuticals; Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA
Erica Powers
Director, Compliance Operations, Sage Therapeutics, Former Director Corporate Compliance, Vertex, Cambridge, MA
Arjun Rajaratnam, JD, MS
Chief Compliance Officer, Smith & Nephew; Former Compliance Officer, US Pharmaceuticals, GlaxoSmithKline; Former Member, PCF Executive Committee; Raleigh, NC
Sunitha Ramamurthy, JD
Head of Compliance, Loxo Oncology, wholly owned subsidiary of Eli Lilly; Former Executive Director, Office of Ethics and Compliance, Boehringer Ingelheim Pharmaceuticals; Stamford, CT
Kristin Rand, JD, MA
Vice President and Compliance Officer, Seattle Genetics, Former Compliance Director, Policy, Ethics, Training & Communication, Genentech, New York, NY
Marc Stephen Raspanti, JD
Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP, Co-chair, White Collar Committee Qui Tam Subcommittee, ABA Criminal Justice Section, Philadelphia, PA
Kelly N. “Nikki” Reeves, MPA, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding LLP, Washington, DC
Lesley C. Reynolds, JD
Partner, Life Sciences Health Industry Group, Reed Smith, Washington, DC
Chapman Richardson
Global Head, Data Consumerization, Sanofi; Former Global Head Next Generation Digital, Novartis; Bridgewater, NJ
Ashley Riley, JD
Senior Manager Deloitte Advisory, Deloitte & Touche LLP, Charlotte, NC
Angela Rodin, MBA
Principal, KPMG, Former Vice President, Global Head of Investigations and Monitoring, GlaxoSmithKline Pharma GmbH, Washington, DC
Jeffrey Rosenbaum, MBA
Partner and Co-founder, Dovetail Consulting Group, LLC, Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA
Amanda Masselam Strachan, JD
Assistant US Attorney and Chief, Health Care Fraud Unit, US Attorney’s Office, District of Massachusetts, US Department of Justice, Boston, MA
Jack Tanselle, MBA
Managing Director, Deloitte & Touche LLP, Indianapolis, IN
Ann-Marie Tejcek, MA
Senior Director North American Ethics & Compliance Officer, Eli Lilly and Company, Indianapolis, IN
Manny Tzavlakis
Managing Partner, Helio Health, Morristown, NJ
Rena Verma, MBA
Senior Managing Director, Information Governance, Privacy and Security Practice, FTI Consulting, New York, NY
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS; Washington, DC
Beth Weinman, JD
Counsel at Ropes & Gray LLP; Former Associate Chief Counsel, FDA; Washington, DC
Elizabeth Weiss, JD
Assistant General Counsel; Chief Compliance Counsel, Pfizer, Peapack, NJ
Caroline West, JD
Global Chief Compliance Officer, Olympus Corporation, Former Sr. VP , Chief Compliance and Risk Officer, Shire, Former VP Global Legal Compliance, Aventis, Philadelphia, PA
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC; Editor, Life Science Compliance Update; Senior Fellow & Adjunct Professor, Life Sciences Compliance at Mitchell Hamline School of Law, West Chester, PA
Jonathan Wilkenfeld, MBA
Partner, Potomac River Partners, Washington, DC
Catherine Williams, JD
Director – Privacy Office, Novo Nordisk, Former Assistant General Counsel, Privacy & K-12, Corrections & Leisure, Aramark, Plainsboro, NJ
Susan Williamson, MBA, CPA
Senior Vice President & Chief Compliance Officer, Endo Pharmaceuticals, Philadelphia, PA
Susan Winkler, JD
Partner, Pierce Bainbridge Beck Price & Hecht LLP, Former Assistant US Attorney and Head, Health Care Fraud Unit, US Attorney’s Office for the District of Massachusetts, Boston, MA
Heather Young, JD
Senior Manager, Compliance Business Partner, Olympus Corporation of the Americas; Former Assistant District Attorney, Office of the District Attorney, City of Philadelphia, Philadelphia, PA
Mark Zaleski, MBA
Director Legal Compliance, Philips; Former Senior Finance Manager, Intel Corporation, Boston, MA
2019-2020 GLOBAL PHARMA COMPLIANCE CONGRESSES
TWENTIETH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November 6 – 8, 2019
Mandarin Oriental, Washington, DC
www.PharmaCongress.com
FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine
Compliance Update
April 20 – 22, 2020
Sheraton Munich Arabellapark Hotel
Munich, Germany
www.InternationalPharmaCongress.com